Bibliography

Congress - Oral presentation

Bédouet, L., Moine, L., Servais, E., Beilvert, A., Pascale, F., Labarre, D., Laurent, A. New drug-eluting beads for sorafenib delivery in HCC embolization. CIRSE 2016. Annual Scientific Meeting, Barcelona, Spain, September 10-14.

Bédouet, L., Moine, L., Servais, E., Beilvert, A., Labarre, D., Laurent, A. Tunable delivery of niflumic acid from resorbable embolization microspheres for uterine fibroid embolization. CIRSE 2016. Annual Scientific Meeting, Barcelona, Spain, September 10-14.

Servais, E., Moine, L., Beilvert, A., Bédouet, L., Laurent, A. A novel radiopaque and colored PEG microspheres for embolization and chemoembolisation. CIRSE 2016. Annual Scientific Meeting, Barcelona, Spain, September 10-14.

Louguet, S., Servais. E., Beilvert, A., Bédouet, L., Verret, V., Pelage, J.-P., Wassef, M., Laurent, A., Moine, L. Poly(ethylene glycol) degradable microspheres as anti-angiogenic carriers for chemoembolization. 10th World Meeting Research Pharm, Glasgow, UK, April 4-8 2016.

Bédouet, L., Servais, E., Beilvert, A., Louguet, S., Laurent, A., Moine, L. Degradable embolization microspheres for local doxorubicin delivery in HCC. 10th World Meeting Research Pharm, Glasgow, UK, April 4-8 2016.

Bédouet, L., Verret, V., Servais, E., Louguet, S., Moine, L., Laurent, A. Doxorubicin, irinotecan and sunitinib: loading and release with a resorbable embolization microsphere (REM). SIR 2013. Annual Scientific Meeting, New Orleans, USA, April 13-18.

Maeda, N., Verret, V., Moine, L., Bédouet, L., Louguet, S., Servais, E., Wassef, M., Osuga, K., Laurent, A. Targeting and recanalization with rapidly resorbable microspheres versus gelatin sponge particles in a pig kidney model. SIR 2013. Annual Scientific Meeting, New Orleans, USA, April 13-18.

Hidaka, K., Verret, V., Bédouet, L., Louguet, S., Servais, E., Moine, L., Osuga, K., Laurent, A. Resorbable embolization microspheres: influence of the addition of ionic charges for drug loading on elasticity and viscoelasticity. SIR 2013. Annual Scientific Meeting, New Orleans, USA, April 13-18. 

Verret, V., Bédouet, L., Maeda, N., Wassef, M., Pascale, F., Louguet, S., Servais, E., Moine, L., Laurent, A. Resorption and recanalization of resorbable embolization microspheres. CIRSE 2012, Lisbon, Portugal, Sept 15-19.

Verret, V., Bédouet, L., Servais, E., Louguet, S., Moine, L., Laurent, A. A rapidly resorbable microsphere for embolization. SIR 2012. Annual Scientific Meeting, San Francisco, USA, March 24-29.

Moine, L., Labarre, D., Lams, A., Wassef, M., Bonneau, M., Nguyen, V., Laurent A.  A novel type of resorbable embolization microspheres with a controlled degradation rate. SIR 2011. Annual Scientific Meeting, Chicago, USA, March 26-31. 

 

Congress - poster

Bédouet, L., Verret, V., Louguet, S., Servais, E., Pascale, F., Moine, L., Laurent, A. Anti-angiogenic bevacizumab (Avastin®) for chemoembolization: a loading and release study with resorbable vs non-resorbable microspheres. CIRSE 2013, September 14-18, Barcelona.

Bédouet, L., Verret, V., Louguet, S., Servais, E., Moine, L., Pascale, F., Moine, L., Laurent, A. Sunitinib (Sutent®) for chemoembolization: a loading and release study with resorbable vs non-resorbable microspheres. CIRSE 2013, September 14-18, Barcelona.

Publications

Laurent, A., Bédouet, L., Moine, L., Wassef, M. 2016. Stealth embolics for uterine fibroid embolization. Int. J. Women’s Health and Wellness, 2:023 .

Bédouet, L., Moine, L., Servais, E., Beilvert, A., Labarre, D., Laurent, A. 2016. Tunable delivery of niflumic acid from resorbable embolization microspheres for uterine fibroid embolization. Int. J. Pharm. 511, 253-261.

Bédouet, L., Verret, V., Louguet, S., Servais, E., Pascale, F., Beilvert, A., Baylatry, MT., Labarre, D., Moine, L., Laurent, A. 2015. Anti-angiogenic drug delivery from hydrophilic resorbable embolization microspheres: an in vitro study with sunitinib and bevacizumab. Int. J. Pharm. 484, 218-227.

Bédouet, L., Pascale, F., Bonneau, M., Laurent, A. 2015. In vitro evaluation of S-(+)-ibuprofen as drug candidate for intra-articular drug delivery system. Drug. Dev. Ind. Pharm. 41, 85-94.

Louguet, S., Verret, V., Bédouet, L., Servais, E., Pascale, F., Wassef, M., Labarre, D., Laurent, A., Moine, L. 2014. Poly(ethylene glycol) methacrylate hydrolyzable microspheres for transient vascular embolization. Acta. Biomater. Mar. 10, 1194-1205.

Verret, V., Pelage, J.P., Wassef, M., Louguet, S., Servais, E., Bédouet, L., Beaulieu, T., Moine, L., Laurent, A. 2014. A novel resorbable embolization microsphere for transient uterine arteries occlusion: a comparative study with trisacryl-gelatin microspheres in the sheep model. J. Vasc. Interv. Radiol. 25, 1759-1766.

Bédouet, L., Moine, L., Pascale, F., Nguyen, V., Labarre, D., Laurent, A. 2014. Synthesis of hydrophilic intra-articular microspheres conjugated to ibuprofen and evaluation of anti-inflammatory activity on articular explants. Int. J. Pharm. 459, 51-61.

Bédouet, L., Pascale, F., Moine, L., Wassef, M., Ghegediban, SH., Nguyen, V., Bonneau, M., Labarre, D., Laurent, A. 2013. Intra-articular fate of degradable poly(ethyleneglycol)-hydrogel microspheres as carriers for sustained drug delivery. Int. J. Pharm. 456, 536-544.

Nguyen, V., Vauthier, C., Huang, N., Grossiord, JL., Moine, L., Agnely, F. 2013. Degradation of hydrolyzable hydrogel microspheres. Soft. Matter. 9, 1929-1936.

Nguyen, V., Huang, N., Grossiord, JL., Moine, L., Agnely, F., Vauthier, C. 2013. Rheological characterization of mechanical properties of chemically crosslinked microspheres. J. Appl. Polym. Sci. 128, 3113-3121

Maeda, N., Verret, V., Moine, L., Bédouet, L., Louguet, S., Servais, E., Osuga, K., Tomiyama, N., Wassef, M., Laurent, A. 2013. Targeting and recanalization after embolization with calibrated resorbable microspheres versus hand-cut gelatin sponge particles in a porcine kidney model. J. Vasc. Interv. Radiol. 24, 1391-1398

Bédouet, L., Pascale, F., Bonneau, M., Wassef, M., Laurent, A. 2011. In vitro evaluation of (S)-ibuprofen toxicity on joint cells and explants of cartilage and synovial membrane. Toxicol. In. Vitro. 25, 1944-1952.